Sustainability at Biocon
Sustainability at Biocon
Philosophy of 'Unconditional Equity'
PATIENT EQUITY
○ 3.1M patients reached
through biosimilars for
diabetes & cancer in FY21
~2B statin pills delivered in
the U.S. in FY21
PEOPLE EQUITY
○ Top 5 among global pharma &
biotech employer since 2012
o Recognized by UN Women for
efforts to promote diversity
FY22
Achievements
О
Biocon 1
SOCIAL EQUITY
Focus on Primary healthcare,
Environmental stability, Rural
development & COVID relief
ENVIRONMENTAL EQUITY
。 53% electricity came from green
power in FY21
。 100% waste water recycled & reused
STAKEHOLDER EQUITY
。 Independent Boards; Professional
Management
○ Board Committees, policies for
global governance
Dow Jones
Sustainability Indexes
-
Featured for 1st time in
2021
Included in 'Emerging Markets
Index' in 2021
Among Top 15 from India
Scored 45 with 93rd percentile
✓ CDP
DISCLOSURE INSIGHT ACTION
Improved score in
2021
Scored 'B' in Climate
Change & Water Security
Click here to view our first ESG Summary Report for FY21
ecovadis
-
-
Secured 'Bronze' place,
improved scores in 2021
Received overall score of 52
Among top 50 companies
assessed
7View entire presentation